← Leaderboards
Arash Grakoui
Emory University
$19,890,946
Attributed
$24,871,323
Total exposure
32
Grants
28
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,913,725 · 33
By mechanism
R01$18,652,393 · 6
U19$14,620,413 · 8
P51$704,997 · 17
R21$498,772 · 1
R56$437,150 · 1
Top collaborators
- Christopher M. Walker5 shared
- Cheng Zhu5 shared
- Zongdi Feng3 shared
- Matthew J Evans2 shared
Most similar at Emory University
Same institution · by research overlap
- Rafi Ahmed$104,632,759
- Rama Rao Amara$90,840,294
- Stefan G Sarafianos$26,943,765
- Guido Silvestri$61,186,493
- Francois J Villinger$61,853,654
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionHepatitis C VirusResponseHepatitis CImmune ResponsePhenotypeViralT-LymphocyteResolutionLiverCd4 Positive T LymphocytesVirusResearch PersonnelVirus DiseasesCellsPreventAcuteAntigensIntrahepaticAntiviral AgentsB-LymphocytesLiver DiseasesDesignUnited States
Grant awards (71)
Correlates of protective immunity to HCV and rational vaccine design$1,633,625
U19 · FY2025 · AI · contact PI
Role of antibodies in hepatitis E virus infection$822,317
R01 · FY2025 · AI
Correlates of protective immunity to HCV and rational vaccine design: Admin Core$326,725
U19 · FY2025 · AI · contact PI
Project-003$326,725
U19 · FY2025 · AI · contact PI
Project-002$326,725
U19 · FY2025 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design$259,994
U19 · FY2025 · AI · contact PI
Core-001$116,532
U19 · FY2025 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design$25,083
U19 · FY2025 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design$2,010,344
U19 · FY2024 · AI · contact PI
Role of antibodies in hepatitis E virus infection$822,317
R01 · FY2024 · AI
Correlates of protective immunity to HCV and rational vaccine design: Project 2$803,843
U19 · FY2024 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design: Admin Core$83,067
U19 · FY2024 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design$2,054,221
U19 · FY2023 · AI · contact PI
Role of antibodies in hepatitis E virus infection$864,317
R01 · FY2023 · AI
Correlates of protective immunity to HCV and rational vaccine design: Project 2$791,335
U19 · FY2023 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design: Admin Core$93,840
U19 · FY2023 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design$2,040,307
U19 · FY2022 · AI · contact PI
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV$669,100
R01 · FY2022 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design: Admin Core$408,062
U19 · FY2022 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design: Project 2$408,061
U19 · FY2022 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design$2,018,828
U19 · FY2021 · AI · contact PI
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV$742,154
R01 · FY2021 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design: Project 2$737,505
U19 · FY2021 · AI · contact PI
Correlates of protective immunity to HCV and rational vaccine design: Admin Core$155,591
U19 · FY2021 · AI · contact PI
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV$747,129
R01 · FY2020 · AI · contact PI
T cell Immunity and the Outcome of Acute HCV Infection$714,861
R01 · FY2020 · AI
T cell compartmentalization and antiviral response$624,373
R01 · FY2020 · AI · contact PI
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV$794,050
R01 · FY2019 · AI · contact PI
T cell Immunity and the Outcome of Acute HCV Infection$729,481
R01 · FY2019 · AI
T cell compartmentalization and antiviral response$624,373
R01 · FY2019 · AI · contact PI
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV$825,277
R01 · FY2018 · AI · contact PI
T cell Immunity and the Outcome of Acute HCV Infection$745,107
R01 · FY2018 · AI
T cell compartmentalization and antiviral response$624,373
R01 · FY2018 · AI · contact PI
T cell Immunity and the Outcome of Acute HCV Infection$758,458
R01 · FY2017 · AI
T cell compartmentalization and antiviral response$692,917
R01 · FY2017 · AI · contact PI
T cell Immunity and the Outcome of Acute HCV Infection$797,768
R01 · FY2016 · AI
T cell compartmentalization and antiviral response$641,320
R01 · FY2016 · AI · contact PI
Mechanisms of hepatitis C virus persistence$440,000
R01 · FY2016 · AI · contact PI
Host and viral determinants of hepatitis C virus macaque infection$263,629
R21 · FY2016 · AI
Mechanisms of hepatitis C virus persistence$440,000
R01 · FY2015 · AI · contact PI
Host and viral determinants of hepatitis C virus macaque infection$235,143
R21 · FY2015 · AI
Mechanisms of hepatitis C virus persistence$440,000
R01 · FY2014 · AI · contact PI
Mechanisms of hepatitis C virus persistence$413,600
R01 · FY2013 · AI · contact PI
Defining the intrahepatic immune response to hepatitis C virus$346,634
R01 · FY2013 · DK · contact PI
Defining the intrahepatic immune response to hepatitis C virus$359,206
R01 · FY2012 · DK · contact PI
Mechanisms of hepatitis C virus persistence$146,666
R01 · FY2012 · AI · contact PI
Mechanisms of hepatitis C virus persistence$437,150
R56 · FY2011 · AI · contact PI
Defining the intrahepatic immune response to hepatitis C virus$359,206
R01 · FY2011 · DK · contact PI
DEFINING THE INTRAHEPATIC IMMUNE RESPONSE TO HEPATITIS C VIRUS$32,906
P51 · FY2011 · RR · contact PI
MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE$32,906
P51 · FY2011 · RR · contact PI
Defining the intrahepatic immune response to hepatitis C virus$437,150
R01 · FY2010 · DK · contact PI
Mechanisms of hepatitis C virus persistence$396,734
R01 · FY2010 · AI · contact PI
IMMUNOLOGICAL STRATEGIES FOR CURING CHRONIC HEPATITIS VIRUS INFECTIONS$43,862
P51 · FY2010 · RR · contact PI
UNDERSTANDING MECHANISMS OF HCV PERSISTENCE$43,862
P51 · FY2010 · RR · contact PI
MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE$43,862
P51 · FY2010 · RR · contact PI
Mechanisms of hepatitis C virus persistence$402,333
R01 · FY2009 · AI · contact PI
IMMUNOLOGICAL STRATEGIES FOR CURING CHRONIC HEPATITIS VIRUS INFECTIONS$54,800
P51 · FY2009 · RR · contact PI
UNDERSTANDING MECHANISMS OF HCV PERSISTENCE$54,800
P51 · FY2009 · RR · contact PI
MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE$54,800
P51 · FY2009 · RR · contact PI
HEPATITIS C VIRUS: DEFINING HOST DETERMINANTS OF INFECTION OUTCOME$54,800
P51 · FY2009 · RR · contact PI
Mechanisms of hepatitis C virus persistence$401,835
R01 · FY2008 · AI · contact PI
ROLE OF NONSTRUCTURAL PROTEINS IN PESTIVIRUS ASSEMBLY$35,600
P51 · FY2008 · RR · contact PI
IMMUNOLOGICAL STRATEGIES FOR CURING CHRONIC HEPATITIS VIRUS INFECTIONS$35,600
P51 · FY2008 · RR · contact PI
UNDERSTANDING MECHANISMS OF HCV PERSISTENCE$35,600
P51 · FY2008 · RR · contact PI
MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE$35,600
P51 · FY2008 · RR · contact PI
HEPATITIS C VIRUS: DEFINING HOST DETERMINANTS OF INFECTION OUTCOME$35,600
P51 · FY2008 · RR · contact PI
Mechanisms of hepatitis C virus persistence$408,701
R01 · FY2007 · AI · contact PI
MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE$39,499
P51 · FY2007 · RR · contact PI
Mechanisms of hepatitis C virus persistence$420,636
R01 · FY2006 · AI · contact PI
HEPATITIS C VIRUS: DEFINING HOST DETERMINANTS OF INFECTION OUTCOME$40,116
P51 · FY2006 · RR · contact PI
HEPATITIS C VIRUS: DEFINING HOST DETERMINANTS OF INFECTION OUTCOME$30,784
P51 · FY2005 · RR